Capricor Therapeutics, Inc. CAPR
8.60 USD -0.32 (-3.59%)
At closeNov 6, 2026, 8:10 AM EST
8.70 +0.10 +1.16%
Pre-market · Nov 6, 8:10 AM ET
8.15 Day range 8.70
2.96 52-week range 40.37
- YTD
- -70.20%
- 1 year
- +38.26%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -108.14M | -42.56M | -24.08M | -29.70M | -20.94M | |
| -105.04M | -40.47M | -22.29M | -29.02M | -20.02M | |
| -2.26 | -1.15 | -0.83 | -1.18 | -0.87 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 287.85M | 11.29M | 14.69M | 9.60M | 34.89M | |
| 355.95M | 170.48M | 58.73M | 50.09M | 41.33M | |
| 50.16M | 25.02M | 36.13M | 38.31M | 9.96M | |
| 14.52M | 1.45M | 2.24M | 2.56M | 2.87M | |
| 305.79M | 145.46M | 22.60M | 11.79M | 31.37M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -69.81M | -40.00M | -25.60M | 4.92M | -16.81M | |
| 97.48M | -116.18M | 5.11M | -35.07M | -1.20M | |
| 248.89M | 152.77M | 25.58M | 4.87M | 20.23M | |
| -11.72M | -1.54M | -2.05M | -3.36M | -1.20M | |
| 276.56M | -3.41M | 5.09M | -25.28M | 2.22M |